Altered proximal T-cell receptor signalling events in mouse CD4+ T cells in the presence of anti-CD4 monoclonal antibodies: Evidence for reduced phosphorylation of Zap-70 and LAT

Scandinavian Journal of Immunology

Volumn 57, Issue 4, 2003, Pages 333-341

  Pullar, C E ^a   Morris, P J ^a   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; LINKER FOR ACTIVATION OF T CELL PROTEIN; OKT 4; PHOSPHOPROTEIN; PROTEIN KINASE ZAP 70; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; TYROSINE; UNCLASSIFIED DRUG; YTS 177; YTS 31;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; FEMALE; IONOMYCIN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PHOSPHOPROTEINS; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0037385274     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01241.x     Document Type: Article

References (57)

1. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol 1998;16:619-44.
2. Schulze-Koops H, Lipsky PE. Anti-CD4 monoclonal antibody therapy in human autoimmune diseases. Curr Dir Autoimmun 2000;2:24-49.
3. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992;54:475-83.
4. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Wood KJ. Kinetics of induction of transplantation tolerance with a non-depleting anti-CD4 monoclonal antibody and donor-specific transfusion before transplantation. Transplantation 1996;61:1642-7.
5. + T cell regulation during the induction phase of the response. Eur J Immunol 1995;25:2643-9.
6. Bushell A, Niimi M, Morris PJ, Wood KJ. Evidence for immune regulation in the induction of transplantation tolerance: a conditional but limited role for IL-4. J Immunol 1999;162:1359-66.
7. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoreguladon of alloresponses. J Immunol 2002;168:1080-6.
8. Wong W, Morris PJ, Wood KJ. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft. Transplantation 1996;62:1462-8.
9. Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-96.
10. Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-recipient micro-chimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. Transplantation 1995;59:1367-71.
11. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for the murine T3 peptide. Proc Natl Acad Sci USA 1987;84:1374-8.
12. Cobbold SP, Waldmann H. Therapeutic potential of monovalent monoclonal antibodies. Nature 1984;308:460-2.
13. Qin S, Cobbold S, Tighe H, Benjamin R, Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 1987;17:1159-65.
14. Granja CB, Gozashti CS, Dasgupta JD. CD4-independent signal transduction through the T-cell receptor. Immunology 1994;83:414-9.
15. Madsen JC, Peugh WN, Wood KJ, Morris PJ. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 1987;44:849-52.
16. Qin SX, Wise M, Cobbold SP et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990;20:2737-45.
17. Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model. J Immunol 1993;151:7249-59.
18. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994;57:1701-6.
19. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-8.
20. Rossini AA, Parker DC, Phillips NE et al. Induction of immunological tolerance to islet allografts. Cell Transplant 1996;5:49-52.
21. Niimi M, Pearson TC, Larsen CP et al. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J Immunol 1998;161:5331-7.
22. Benjamin RJ, Cobbold SP, Clark MR, Waldmann H. Tolerance to rat monoclonal antibodies. Implications for serotherapy. J Exp Med 1986;163:1539-52.
23. Benjamin RJ, Waldmann H. Induction of tolerance by monoclonal antibody therapy. Nature 1986;320:449-51.
24. Gutstein NL, Seaman WE, Scott JH, Wofsy D. Induction of immune tolerance by administration of monoclonal antibody to L3T4. J Immunol 1986;137:1127-32.
25. Madsen JC, Wood KJ, Morris PJ. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection. Transplant Proc 1987;19:3991-2.
26. Hall BM. Therapy with monoclonal antibodies to CD4: potential not appreciated? Am J Kidney Dis 1989;14 (Suppl. 2):71-7.
27. Qin S, Cobbold SP, Pope H et al. "Infectious" transplantation tolerance. Science 1993;259:974-7.
28. Darby CR, Bushell A, Morris PJ, Wood KJ. Nondepleting anti-CD4 antibodies in transplantation. Transplantation 1994;57:1419-26.
29. Bank I, Chess L. Perturbation of the T4 molecule transmits a negative signal to T cells. J Exp Med 1985;162:1294-303.
30. Tite JP, Sloan A, Janeway Jr CA. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal. J Mol Cell Immunol 1986;2:179-90.
31. Bartholomew M, Brett S, Barber K, Rossman C, Crowe S, Tite J. Functional analysis of the effects of a fully humanized anti-CD4 antibody on resting and activated human T cells. Immunology 1995;85:41-8.
32. Holdorf AD, Lee KH, Burack WR, Allen PM, Shaw AS. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat Immun 2002;3:259-64.
33. Wange RL, Samelson LE. Complex complexes: signaling at the TCR. Immunity 1996;5:197-205.
34. Veillette A, Bolen JB, Bookman MA. Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor oft lymphocytes. Mol Cell Biol 1989;9:4441-6.
35. Alexander DR. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin Immunol 2000;12:349-59.
36. Isakov N, Biesinger B. Lck protein tyrosine kinase is a key regulator of T-cell activation and a target for signal intervention by Herpes-virus saimiri and other viral gene products. Eur J Biochem 2000;267:3413-21.
37. Duplay P, Thome M, Herve F, Acuto O. p561ck interacts via its src homology 2 domain with the ZAP-70 kinase. J Exp Med 1994;179:1163-72.
38. Wange RL, Guitian R, Isakov N, Watts JD, Aebersold R, Samelson LE. Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J Biol Chem 1995;270:18730-3.
39. Van Oers NSC, Kileen N, Weiss A. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J Exp Med 1996;183:1053-62.
40. Weiss A, Koretzky G, Schatzman RC, Kadlecek T. Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-gamma I. Proc Nat Acad Sci USA 1991;88:5484-8.
41. Bustelo XR, Ledbetter JA, Barbacid M. Product of vav protooncogene defines a new class of tyrosine protein kinase substrates. Nature 1992;356:68-71.
42. Donovan JA, Wange RL, Langdon WY, Samelson LE. The protein product of the c-cbl protooncogene is the 120kDa tyrosine phosphorylated protein in Jurkat cells activated by the T cell antigen receptor. J Biol Chem 1994;269:22921-4.
43. Jackman JK, Motto DG, Sun Q et al. Molecular cloning of SLP-76, a 76kDa tyrosine phosphoprotein associated with grb2 in T cells. J Biol Chem 1995;270:7029-32.
44. Weber JR, Orstavik S, Torgersen KM et al. Molecular cloning of the cDNA encoding pp36, a tyrosine phosphorylated adaptor protein selectively expressed by T cells and natural killer cells. J Exp Med 1998;187:1157-61.
45. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998;92:83-92.
46. Paz PE, Wang S, Clarke H, Lu X, Stokoe D, Abo A. Mapping the Zap-70 phosphorylation sites on LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells. Biochem J 2001;356:461-71.
47. Cantrell D. T cell antigen receptor signal transduction pathways. Annu Rev Immunol 1996;14:259-74.
48. Bosselut R, Zhang W, Ashe JM, Kopacz JL, Samelson LE, Singer A. Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction. J Exp Med 1999;190:1517-26.
49. Fehervari Z, Cooke A, Brett S, Turner J. Perturbation of naïve TCR transgenic T cell functional responses and upstream activation events by and-CD4 monoclonal antibodies. Eur J Immunol 2002;32:333-40.
50. Chambers CA, Allison JP. Co-stimulation in T cell responses. Curr Biol 1997;9:396-404.
51. + T cells. Science 1996;271:1276-8.
52. Schwartz RH. T cell anergy. Annu Rev Immunol 2002;5:5.
53. McKay DB, Irie HY, Hollander G et al. Antigen-induced unresponsiveness results in altered T cell signaling. J Immunol 1999;163:6455-61.
54. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM. Partial T cell signaling: altered phospho-z and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell 1994;79:913-22.
55. Gajewski TF, Qian D, Fields P, Fitch FW. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc Natl Acad Sci USA 1994;91:38-42.
56. Peterson EJ, Clements JL, Fang N, Koretzky GA. Adaptor proteins in lymphocyte antigen, receptor signaling. Curr Opin Immunol 1998;10:337-44.
57. Lin J, Weiss A. Identification of the minimal tyrosine residues required for linker for activation of T cell function. J Biol Chem 2001;276:29588-95.